PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free ...
Administering BCG and OPV within 48 hours of birth reduces neonatal mortality, especially in low-birth-weight babies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback